Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms-A randomized controlled trial.

Hao Xiang Chen Shih-Hsin Chang Der-Yuan Chen Joung-Liang Lan Kai-Jieh Yeo Po-Hao Huang Chung-Ming Huang Chi-Ping Huang Eric Chieh-Lung Chou Po-Chang Wu

Published in: Lower urinary tract symptoms (2023)

Our study showed that mirabegron is equally effective as solifenacin in treating Sjogren's syndrome patients with overactive bladder. Mirabegron is superior to solifenacin in terms of treatment-related adverse events.

Keyphrases

case report
depressive symptoms
sleep quality
replacement therapy
drug induced